临床神经电生理学杂志
臨床神經電生理學雜誌
림상신경전생이학잡지
JOUNRNAL OF CLINICAL ELECTRONEUROPHYSIOLOGY
2001年
1期
7-11
,共5页
逐点测试%嵌压性神经病%定位诊断
逐點測試%嵌壓性神經病%定位診斷
축점측시%감압성신경병%정위진단
目的:研究逐点测试对嵌压性神经病的定位诊断价值。方法:对58例确诊的累及运动功能的嵌压性单神经病患者进行受累神经干上间隔2cm的逐步测试,并同时给予常规神经电图检查。结果:58例76条神经中51例(88%)65条神经(85%)跨嵌压段一项或几项指标异常,其中波幅明显衰减60条(79%),传导减慢40条(53%),潜伏期延长42条(55%),波形显著变化55条(72%),波宽显著变化54条(71%)。阳性率最高的表现是波幅降低。与常规神经电图总的阳性率为60%(46条)作比较,逐点测试阳性率明显提高(P<0.01)。结论:逐点测试对嵌压性单神经病有重要的定位诊断价值,其中跨嵌压段波幅的显著衰减比传导速度的减慢有更高的阳性率
目的:研究逐點測試對嵌壓性神經病的定位診斷價值。方法:對58例確診的纍及運動功能的嵌壓性單神經病患者進行受纍神經榦上間隔2cm的逐步測試,併同時給予常規神經電圖檢查。結果:58例76條神經中51例(88%)65條神經(85%)跨嵌壓段一項或幾項指標異常,其中波幅明顯衰減60條(79%),傳導減慢40條(53%),潛伏期延長42條(55%),波形顯著變化55條(72%),波寬顯著變化54條(71%)。暘性率最高的錶現是波幅降低。與常規神經電圖總的暘性率為60%(46條)作比較,逐點測試暘性率明顯提高(P<0.01)。結論:逐點測試對嵌壓性單神經病有重要的定位診斷價值,其中跨嵌壓段波幅的顯著衰減比傳導速度的減慢有更高的暘性率
목적:연구축점측시대감압성신경병적정위진단개치。방법:대58례학진적루급운동공능적감압성단신경병환자진행수루신경간상간격2cm적축보측시,병동시급여상규신경전도검사。결과:58례76조신경중51례(88%)65조신경(85%)과감압단일항혹궤항지표이상,기중파폭명현쇠감60조(79%),전도감만40조(53%),잠복기연장42조(55%),파형현저변화55조(72%),파관현저변화54조(71%)。양성솔최고적표현시파폭강저。여상규신경전도총적양성솔위60%(46조)작비교,축점측시양성솔명현제고(P<0.01)。결론:축점측시대감압성단신경병유중요적정위진단개치,기중과감압단파폭적현저쇠감비전도속도적감만유경고적양성솔
Objectives: To study the location diagnostic value of inchingtest in compressive neuropathy.Methods: The inching test was performed in 48 patients with compressive simple neuropathy with motor function involved,and the rourtine EMG was done.Results: one or more indexes of inching test were abnormal in 65 nerves(85%), among 76 ones detected. The decrease of amplitude, of conduction velocity and prolongation of latency was noted in 60 nerves(79%), 40 ones (53%) and 42(55%) respectively. The significant changes of wave form and wave duration was found in 55 nerves (72%) and 54(71%) respectively. The total positivity rate of the electroneurogram was 61%.Conclusions: The inching test might have an important role in the location diagnosis of compressive simple neuropathy. The significant decrement of amplitude might have higher posstivity rate as compared with that of the decreace of the conduction velocity. The degree of amplitude decrease might have a guide role in the choice of treatment meghod.